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Abstract
Background: Survivin is a unique member of the inhibitor of apoptosis protein (IAP) family in that it exhibits
antiapoptotic properties and also promotes the cell cycle and mediates mitosis as a chromosome passenger
protein. Survivin is highly expressed in neural precursor cells in the brain, yet its function there has not been
elucidated.
Results: To examine the role of neural precursor cell survivin, we first showed that survivin is normally expressed
in periventricular neurogenic regions in the embryo, becoming restricted postnatally to proliferating and migrating
NPCs in the key neurogenic sites, the subventricular zone (SVZ) and the subgranular zone (SGZ). We then used a
conditional gene inactivation strategy to delete the survivin gene prenatally in those neurogenic regions. Lack of
embryonic NPC survivin results in viable, fertile mice (SurvivinCamcre) with reduced numbers of SVZ NPCs, absent
rostral migratory stream, and olfactory bulb hypoplasia. The phenotype can be partially rescued, as
intracerebroventricular gene delivery of survivin during embryonic development increases olfactory bulb
neurogenesis, detected postnatally. SurvivinCamcre brains have fewer cortical inhibitory interneurons, contributing to
enhanced sensitivity to seizures, and profound deficits in memory and learning.
Conclusions: The findings highlight the critical role that survivin plays during neural development, deficiencies of
which dramatically impact on postnatal neural function.
Background
In the adult, two major, well-defined neurogenic regions
persist [1]. In the subventricular zone (SVZ), neural pre-
cursor cells (NPCs) that arise mostly from the embryo-
nic lateral ganglionic eminence (LGE) [2], continuously
proliferate, and then migrate tangentially along the ros-
tral migratory stream (RMS) towards the olfactory bulb
(OB) where they differentiate into granular and periglo-
merular inhibitory interneurons [3]. In the subgranular
zone (SGZ) of the hippocampus, newborn NPCs also
migrate, but for shorter distances, into the granule cell
layer, where they become excitatory granule cells [4].
From these neurogenic sites, adult-generated neurons
can migrate to regions of brain injury [5], and establish
synaptic contacts and functional connections [6,7].
Decreased neurogenesis induced by prenatal or postnatal
stresses is implicated in the development of seizures and
disorders in learning, memory and cognition [8,9]. The
possibility of preventing onset or progression of these
neural diseases by therapeutically enhancing neurogen-
esis [10-15] is prompting efforts to delineate the
mechanisms and regulatory factors underlying NPC sur-
vival, proliferation, differentiation, migration and func-
tion. Indeed, numerous neuro-regulatory transcription
factors, growth factors and receptors have been identi-
fied and characterized (reviewed in [16-19]). However,
in spite of advances, effective approaches to prevent and
treat diseases of the central nervous system are lacking,
underlining the urgent need to develop better models to
elucidate the molecular mechanisms regulating
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integration of new neurons in the developing and adult
brain. Survivin is a member of the inhibitor of apoptotis
protein (IAP) family, that also promotes the cell cycle
and is a chromosome passenger protein [20,21]. During
embryonic development, it is expressed by several tis-
sues, but is particularly prominent in the nervous system
[22]. Inactivation of the survivin gene in neuroepithelial
cells early in development [23] results in massive apop-
tosis throughout the central nervous system, with total
destruction of the architecture of the brain and lethality.
The severity of this phenotype precluded investigators
from delineating the specific role of neural precursor
cell survivin on postnatal neural function.
Therefore, to elucidate the properties of survivin in
neural development and function, we inactivated the
survivin gene in NPCs in the late-midterm murine
embryo and evaluated the effects post-natally. By this
approach, we generated a unique in vivo mouse model
in which reduced neurogenesis is associated with epi-
lepsy and profound deficits in learning and memory.
Pilot rescue studies suggest that embryonic administra-
tion of survivin may enhance neurogenesis. The findings
highlight the critical role that survivin plays during
neural development, deficiencies of which dramatically
impact on postnatal neural function.
Results
Survivin is expressed in precursor cells in the neurogenic
areas of the brain
In situ hybridization using a probe against full length
survivin allowed assessment of the spatiotemporal
expression of survivin during embryonic development.
Survivin mRNA was detected in the neurogenic areas of
the dorsal and ventral telencephalon surrounding the
ventricles (neocortex, medial and lateral ganglionic emi-
nences (MGE and LGE, respectively)) (Figure 1A). At
E12.5, expression of survivin overlapped with Dlx1, a
marker for mitotic cells in the MGE and LGE [24] (Fig-
ure 1A, D) and neurogenin 2 (Ngn2) [25], a marker for
dividing precursors in the neocortex (Figure 1A, C).
There was minimal overlap with Dlx5 (Figure 1B),
which is primarily expressed by postmitotic cells in the
mantle zone of the MGE and LGE, less so in mitotic
cells in the SVZ, and almost absent in the ventricular
zone [26]. By E17.5, survivin was additionally expressed
in the rostral migratory stream (RMS) and at the center
of the olfactory bulb (OB) (Figure 1G, I, K). Survivin
mRNA was also present in the retina and lens of the
developing eye (not shown).
Postnatally, survivin expression was restricted largely
to rapidly proliferating cells [21] and migrating NPCs
[27]. At P7, survivin mRNA was detected in the SVZ,
the RMS, the OB, and the dentate gyrus (DG) (Figure
2A, C, D, E). Within the SVZ, survivin was not
expressed in the ependymal cells immediately adjacent
to the lateral ventricle (Figure 2C, D). During the first
two postnatal weeks, survivin mRNA was also detected
in granule cell precursors in the external germinal layer
(EGL) of the developing cerebellum (Figure 2A). In the
adult brain, survivin expression remained restricted to
proliferating and migrating precursor cells in the SVZ,
the RMS, and the subgranular zone (SGZ) of the DG
(Figure 2F, H).
In both the SVZ (Figure 2J-L) and the SGZ of the DG
(Figure 2M-O), >95% of survivin expressing cells were
positive for the proliferation marker PCNA, while at
both sites, 25-50% of PCNA positive cells expressed sur-
vivin. Thus, survivin expressing cells represent a subpo-
pulation of the mitotically active cells. Doublecortin
(DCX), present in immature, migrating neuroblasts [28]
also overlapped with survivin in the SVZ, the RMS and
the SGZ. However, similar to PCNA, not all DCX posi-
tive cells expressed survivin, indicating that survivin is
restricted to a subpopulation of cells in the SVZ-RMS
(not shown). Mature neuronal marker NeuN [29] immu-
noreactivity did not overlap with survivin, consistent
with the lack of survivin expression by mature neurons
(Figure 2C-E).
Overall, survivin expression is restricted during fetal
development to NPCs in neurogenic regions of the tele-
ncephalon, of which a fraction populates the major neu-
rogenic regions of the postnatal brain, i.e. the SVZ and
the SGZ. Within these neurogenic regions, a subpopula-
tion of NPCs continues to express survivin, which is
downregulated once the cells differentiate into neurons.
In both the embryo or adult, survivin is not detected in
neurons in the cortex, OB, or hippocampus.
In vivo Prenatal Survivin gene inactivation
To study the in vivo role of NPC survivin, we generated
mice in which the survivin gene is inactivated in the
neurogenic regions of the brain prenatally. Mice expres-
sing cre recombinase driven by the CamKIIa promoter
[30,31] were bred with mice in which the entire survivin
gene is flanked by loxP sites [32]. The resultant Cam-
KIIa-cre:survivinlox/lox (referred to as SurvivinCamcre)
mice were born in the expected Mendelian distribution,
i.e. there was no evidence of embryonic lethality.
We confirmed previous reports of cre recombinase
activity in the CAMKIIa-cre embryos and mice [30,31]
by breeding the CAMKIIa-cre mice with the ROSA26
reporter mice, followed by immunohistochemical detec-
tion of GFP. Cre recombinase activity at E12.5 was
detected prominently in the ventral telencephalon
(ganglionic eminences), but less in the dorsal telence-
phalon, and not in the eye (Additional file 1: Supple-
mental Figure S1). Postnatally, it was restricted to
postmitotic NeuN positive neurons in the hippocampus
and cortex, with lower levels in the striatum, thalamus,
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Figure 1 Expression of survivin mRNA in developing mouse brain. In situ hybridizations were performed on coronal brain sections from
control (wt) (A-D, G, I, K) and SurvivinCamcre (ko) (H, J, L) embryos, and on transverse brain sections from control (E) and SurvivinCamcre (F)
embryos. (A-D) mRNA expression of survivin (A), dlx5 (B), ngn2 (C), and dlx1 (D) on adjacent brain sections from control mice illustrates overlap
of survivin expression with dlx1 and ngn2. Dashed white line (A, B) indicates minimal overlap of survivin with dlx5. (E-L) Expression of survivin
mRNA is reduced in the medial and lateral ganglionic eminences (MGE, LGE) (F, H), the RMS (arrow, J), and the OB (L) in SurvivinCamcre embryos
as compared to controls. NCX, neocortex; HP, hippocampus. Scale bars: 500 μm
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Figure 2 Postnatal expression of survivin mRNA in neural precursor cells. Sagittal sections of brains were used to examine expression of
survivin. (A, B) At P7, Survivin mRNA was detected in the DG, SVZ, RMS, OB, and EGL of controls (A), and absent in the SVZ and RMS, but not in
the DG and EGL of SurvivinCamcre mouse brains (B). (C-E) Double labeling to detect survivin mRNA (blue) and NeuN protein (orange) expression
in the SVZ-RMS (C, D) and the DG (E) in P7 control brains, shows that survivin is not expressed in NeuN+ cells. D is a magnified view of the
dashed box in C. (F-I) Survivin mRNA expression at P35 is restricted to neural precursor cells in the SVZ, RMS and SGZ in control mice (F, H).
Survivin expression is reduced in the SVZ and RMS (G), but not in the SGZ (I) of SurvivinCamcre mice (ko) as compared to controls (wt). (J-O)
Sagittal sections of control P7 brains through the SVZ (J-L) and through the SGZ (M-O) were stained for PCNA (red nuclei) (J, M) and survivin
mRNA (white cytoplasm) (K, N) and the confocal images were overlaid (L, O). Only a subpopulation of PCNA+ cells express survivin. EGL, external
germinal layer; OB, olfactory bulb; LV, lateral ventricle. Scale bars: A, B 1000 μm; C, F, G 500 μm; D 50 μm; E 200 μm; H, I 100 μm, J-O 20 μm.
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hypothalamus and amygdala [30]. Postnatal cre expres-
sion was absent in NPCs in the SVZ and SGZ (Addi-
tional file 1: Supplemental Figure S2). Thus, cross-
breeding with the Survivinlox/lox mice resulted in dele-
tion of both survivin alleles in the neurogenic regions in
the prenatal period (ganglionic eminences and
neocortex).
Neurogenesis defects in SurvivinCamcre embryos
Cre excision of survivin was assessed by in situ hybridi-
zation in SurvivinCamcre and corresponding control Sur-
vivinlox/lox embryos. At E14.5 and E17.5, survivin
expression in the SurvivinCamcre embyros was markedly
reduced in the ganglionic eminences surrounding the
lateral ventricles where mitotically active NPCs normally
reside, in the RMS and in the OB (Figure 1F, H, J, L).
This was associated with increased tunel staining, most
evident in the ganglionic eminences, and minimally in
the dorsal telencephalon (Figure 3A-D). BrdU labeling
studies revealed decreased NPC proliferation in the
SVZ, RMS and OB of E17.5 SurvivinCamcre embryos
(Figure 3E-J). Thus, lack of NPC survivin results in
increased embryonic NPC death and decreased NPC
proliferation in specific embryonic neurogenic regions.
Altered postnatal neurogenesis in SurvivinCamcre mice
Body weights of SurvivinCamcre and control mice were
not significantly different at birth. However, during the
first month after birth, SurvivinCamcre mice had a signifi-
cantly higher mortality rate of 28% (n = 27/95)
compared to 0% (n = 0/97) in control mice. Adult Survi-
vinCamcre mice also had significantly smaller brains, and
the OBs were strikingly hypoplastic (Figure 4A, B) (for
brains: 421 ± 11 gm versus 329 ± 7 gm, for controls ver-
sus SurvivinCamcre, respectively, p < 0.001; for OBs: 19.7
± 0.9 gm versus 3.5 ± 0.2 gm for controls versus Survi-
vinCamcre, p < 0.001; n = 6 mice per group). In situ
hybridization confirmed loss of survivin expression in
the SVZ and RMS (Figure 2A, B, F, G). Surprisingly,
expression of survivin in the SGZ was not decreased
postnatally in SurvivinCamcre mice (Figure 2I). Nissl
stained brain sections from SurvivinCamcre mice revealed
loss of the RMS, decreased cortical thickness (average
reduction to 80% of control at bregma levels -1.34/-
1.70/-2.46/-2.80 mm; n = 4 mice per group, p < 0.01 at
each bregma level), enlarged ventricles, yet no morpho-
logical changes in the hippocampus (Figure 4C, D). The
latter was confirmed by quantifying the volumes corre-
sponding to the GCL and the hilus of the DG (GCL:
0.11 ± 0.01 mm3 versus 0.12 ± 0.01 mm3 for control
and SurvivinCamcre mice, respectively; hilus: 0.11 ± 0.01
mm3 versus 0.15 ± 0.02 mm3 for control and Survivin-
Camcre mice, respectively; n = 4-5 mice per group, p >
0.05).
The hypoplastic OB and absent RMS, in concert with
reduced expression of NPC survivin in the Survivin-
Camcre mice might be caused by decreased NPC prolif-
eration, increased cell death, and/or deficits in
Figure 3 Neurogenesis defects in SurvivinCamcre embryos. (A-D) Tunel labeling of coronal sections of E14.5 brains illustrates increased
number of apoptotic cells in the ganglionic eminences (GE) of SurvivinCamcre embryos (arrows). (E-J) BrdU immunostaining of coronal sections of
E17.5 embryos reveals reduced cell proliferation in the SVZ, the RMS (arrow in G, H), and the OB of SurvivinCamcre embryos as compared to
controls. NCX, neocortex; HP, hippocampus. Scale bars: 500 μm
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Figure 4 Altered neurogenesis in adult SurvivinCamcre mice. (A, B) Dorsal view of control (wt) and SurvivinCamcre (ko) whole brains at 16
weeks, reveals OB hypoplasia in SurvivinCamcre mice. (C, D) Nissl stained sagittal sections of littermates, shows thinner cortex (double arrow) and
absence of the RMS in the SurvivinCamcre mice. (E, F, I, J) BrdU labeling of sagittal sections of brains from 12 week old mice shows proliferation
in the SVZ-RMS pathway (E, F) and in the SGZ (I, J), that is reduced only in the SVZ of SurvivinCamcre mice (F) as compared with controls (E). (G,
H) DCX immunostaining of sagittal sections through the forebrain of control (G) and SurvivinCamcre (H) mice. (M, O) Quantification of BrdU+ cells
in the SVZ (M) and the SGZ (O) was performed as detailed in Methods. There was a significant reduction in BrdU+ cells in the SVZ, but not in
the SGZ of SurvivinCamcre mice as compared to controls. (K, L) Coronal sections through the anterior SVZ of control (K) and SurvivinCamcre (L) mice
were stained for tunel+ apoptotic cells (arrows). (N, P) The number of tunel+ cells in the SVZ (N) and the SGZ (P) of control and SurvivinCamcre
mice was quantified as described in Methods. There was a significant increase in tunel+ cells in the SVZ but not in the SGZ of SurvivinCamcre
mice as compared to controls. LV, lateral ventricle. Results in panels M, N, O, P are reflected as means + SEM, n = 4-5 mice per group. *P <
0.005. Scale bars: A-D 2 mm; E-H 500 μm; I-L 100 μm. (C-L) 12 weeks.
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migration. Accumulation of cells in the anterior SVZ of
the SurvivinCamcre mice was not observed, mitigating
against a predominant migration defect. NPC prolifera-
tion, assessed 1 hr after a single dose of BrdU, revealed
a significant reduction in BrdU labeled cells in the SVZ
of the SurvivinCamcre mice (132 ± 16 cells versus 57 ± 8
cells for control and SurvivinCamcre mice, respectively, n
= 4-5 mice per group, p = 0.002) (Figure 4E, F, M).
Furthermore, both BrdU and DCX labeled cells were
almost completely absent in the RMS, in striking con-
trast to the controls (Figure 4E-H). Cell death in the
SVZ of the SurvivinCamcre mice was also significantly
increased (Figure 4K, L, N), as quantified by the number
of tunel+ cells in the anterior SVZ (1.5 + 0.21/100
nucleated cells versus 3.5 + 0.46 tunel+ cells/100
nucleated cells, for control and SurvivinCamcre mice,
respectively, n = 4-5 mice per group, p = 0.004) (Figure
4N). In the RMS and OB, there were some tunel+ cells
identified in the brains of the control mice, but not in
SurvivinCamcre mice, the latter likely due to the lack of
precursor cells in this region.
As noted above, survivin expression in the SGZ of the
DG was not appreciably diminished after cre excision.
There was also no alteration in the number of prolifer-
ating or immature neurons in the SGZ, as quantified by
BrdU labeling (1010 + 88 versus 905 + 75 cells in con-
trols and SurvivinCamcre mice, respectively, n = 4-5 mice
per group, p = 0.39) (Figure 4I, J, O) or DCX immunor-
eactivity (not shown). Nor could we detect changes in
tunel+ staining (2.3 + 0.18 versus 1.6 + 0.63 tunel+
cells/section in controls and SurvivinCamcre mice, respec-
tively, n = 3-4 mice per group, p = 0.30) (Figure 4P).
In summary, striking survivin-dependent defects in
neurogenesis are evident postnatally in the RMS and OB
of SurvivinCamcre mice, due to a combination of
increased SVZ NPC apoptosis and diminished cellular
proliferation. Despite the fetal abnormalities, and in
striking contrast to the RMS-OB, there were no obvious
structural defects or alterations in hippocampal neuro-
genesis in the SurvivinCamcre mice that had no appreci-
able reduction in survivin expression within the
hippocampus.
Embryonic survivin administration increases neurogenesis
In pilot studies, we assessed whether prenatal adminis-
tration of survivin to increase expression in NPCs could
promote neurogenesis. E12.5 control Survivinlox/lox and
SurvivinCamcre embryos received an intracerebroventricu-
lar injection in utero with the lentiviral vector
pCHMWS-eGFP-T2A-SRV140 (survivin vector) or
pCHMWS-eGFP-T2A-Fluc (control vector). At P21,
immunohistochemical analysis of the control Survivinlox/
lox mice that received the survivin vector revealed an
increased number of embryonic precursor cell-derived
cells in the OB as compared with the control vector
(Additional file 1: Supplemental Figures S3A, B). With
SurvivinCamcre embryos, the survivin vector did not
apparently reverse the OB hypoplasia when examined at
P21, but there were notably more embryonic precursor
cell-derived cells in the OB of 3 out of 3 SurvivinCamcre
mice that received the survivin vector, as compared with
the 2 SurvivinCamcre mice that received the control vec-
tor (Additional file 1: Supplemental Figures S3C, D).
Overall, these preliminary findings suggest that
enhanced expression of NPC survivin may increase
neurogenesis.
SurvivinCamcre mice have a thinner cortex with fewer
GABAergic interneurons and a lower seizure threshold
Although the average cortical thickness in the Survivin-
Camcre mice was reduced, in situ hybridization with cor-
tical markers (Cux2 for layers 2-4 [33], Badlamp for
layers 2/3/5 [34], and ER81 for layer 5 [35] confirmed
the correct orientation and presence of all the cortical
layers (not shown). Moreover, and in line with limited
expression of cre recombinase in the dorsal telencepha-
lon of CamKIIa-cre embryos, the density of cortical
vGLUT1+ glutamatergic cells in the SurvivinCamcre mice
was not altered (2282 + 157 cells/mm2 versus 2480 + 71
cells/mm2 in controls and SurvivinCamcre mice, respec-
tivley, n = 4-5 mice per group, p = 0.30) (Figure 5A-C).
In contrast, and consistent with prominent apoptosis
and diminished BrdU labeling in the ganglionic emi-
nences, prenatal depletion of survivin in the NPCs of
SurvivinCamcre mice resulted in a significant reduction in
the density of GAD65/67+ GABAergic interneurons in
the postnatal adult cortex (493 + 12 cells/mm2 versus
417 + 6 cells/mm2 in controls and SurvivinCamcre mice,
respectively, n = 5-6 mice per group, p < 0.001) (Figure
5D-F). This occurred in the absence of any changes in
interneurons in the hippocampus (hilus + granular cell
layer: 213 ± 8 cells/mm2 versus 209 ± 17 cells/mm2 in
controls and SurvivinCamcre mice, respectively, n = 4
mice per group, p = 0.82). These data indicate an altera-
tion in the excitatory/inhibitory balance in the brain of
SurvivinCamcre mice that might be associated with post-
natal alterations in cognition and behavior, and a lower
seizure threshold.
Indeed, during routine handling, 2.5% (n = 9/352) of
the SurvivinCamcre mice were recorded to have sponta-
neous tonic-clonic, generalized motor seizures starting
from 2 weeks of age (no seizures observed in controls).
To investigate seizure susceptibility, the response of
control and SurvivinCamcre mice to kainic acid (KA) was
assessed over a period of 2 hours. Control, saline-treated
animals (n = 9 per group) showed no signs of epileptic
activity. However, in response to KA, SurvivinCamcre
mice exhibited a lower threshold for seizures that were
more severe. Thus, at a subconvulsive dose of 20 mg/kg,
KA induced limbic motor convulsions in 15% (n = 2/13)
Coremans et al. BMC Neuroscience 2010, 11:2
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of control mice and 81% (n = 13/16) SurvivinCamcre mice
(Figure 6A). The maximum seizure score was signifi-
cantly higher in the SurvivinCamcre mice (p < 0.001). Sei-
zure severity over the 2 hr observation period was also
significantly greater in the SurvivinCamcre mice (p <
0.001) (Figure 6B). At a KA dose of 30 mg/kg, the mean
latency to the first seizure was also shorter in the Survi-
vinCamcre mice compared to control mice (8.75 ± 2.75
versus 30 ± 7.64 min, respectively, n = 4 mice per
group, p = 0.031). At that dose, all SurvivinCamcre mice
rapidly developed status epilepticus (stage 5-6) and died
of severe generalized convulsions, while all control ani-
mals survived the KA treatment (Figure 6A). Thus, Sur-
vivinCamcre mice exhibit enhanced susceptibility to KA
seizures.
Neuropeptide Y (NPY) is a multifunctional peptide
that is expressed in GABAergic interneurons, regulates
pre-synaptic excitatory transmission in the DG, and has
anti-epileptic properties [36]. Hilar NPY interneuron
degeneration, ectopic expression of NPY in mossy fibers,
and axonal sprouting are common features of limbic
hyperexcitability [37]. Due to the increased seizure activ-
ity in the SurvivinCamcre mice, we examined NPY expres-
sion under both basal conditions (saline treatment) and
following induction of seizures (KA 20 mg/kg i.p.). The
number of hilar NPY+ interneurons was not different
between saline-treated control and SurvivinCamcre mice
(490 ± 17 versus 398 ± 53 cells/mm2, for control and
SurvivinCamcre mice, respectively; n = 4-5 mice per
group, p = 0.11). However, two weeks after 20 mg/kg
KA treatment, there were significantly fewer NPY+ cells
in the hilus of the SurvivinCamcre mice (446 ± 22 versus
306 ± 65 cells/mm2 for control and SurvivinCamcre mice,
respectively; n = 6-9 mice per group, p = 0.032). More-
over, ectopic NPY expression in mossy fibers was readily
detected in 3 out of 4 saline-treated SurvivinCamcre mice
but not in any of the corresponding controls (n = 5)
(Figure 6C, D). This effect became more prominent
after KA (5/6 SurvivinCamcre mice as compared to 0/9
controls). In 2 of these SurvivinCamcre mice, we further-
more observed ectopic NPY immunoreactivity in the
supragranular layer, likely reflecting sprouting of mossy
fibers (not shown).
Since seizure activity modulates hippocampal neuro-
genesis, we also evaluated the seizure-induced neuro-
genic response of the control and SurvivinCamcre mice.
The volumes of the GCL and the hilus were not differ-
ent between control and SurvivinCamcre mice (see
above), and KA had no effect on that relationship (data
not shown). To assess cell proliferation, BrdU was
injected 3 days after KA or saline injection, and mice
were sacrificed 1 day later. After saline injection, the
total number of SGZ BrdU+ cells was not different in
control and SurvivinCamcre mice (648 ± 58 cells versus
705 ± 99 cells in controls and SurvivinCamcre mice,
respectively, n = 4 mice per group, p = 0.64) (Figure
Figure 5 GABAergic and glutamatergic inter/neurons. In situ hybridizations of coronal sections were performed to detect and quantify
vGLUT1+ glutamatergic neurons (A-C) and GAD65/67+ GABAergic interneurons (D-F) in adult littermates. (A-C) In spite of SurvivinCamcre mice
having a thinner cortex, the density of vGLUT1+ cells in the cortex was not signficantly different between SurvivinCamcre and control mice. (D-F)
The density of GAD65/67+ cells in the cortex was significantly reduced in SurvivinCamcre mice, but not in the hippocampus (see text). Results in
panels B and E are reflected as means + SEM, n = 4-6 mice per group. **P < 0.001 Scale bars: 500 μm.
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6E). Compared to saline treated controls, KA treated
mice exhibited an increase in the number of BrdU+
cells in the SGZ after KA injection. However, the neuro-
genic response was significantly dampened in the Survi-
vinCamcre KA treated mice compared to control KA
treated mice (3578 ± 392 cells versus 1955 ± 233 cells
for controls and SurvivinCamcre mice, respectively, n = 5
mice per group, p < 0.001) (Figure 6E). Numbers of
BrdU+ cells remained reduced 2 weeks following KA in
the SurvivinCamcre mice as compared to controls (data
not shown). Thus, despite the higher seizure scores fol-
lowing KA in the SurvivinCamcre mice, there was less sei-
zure-induced neurogenesis in the SurvivinCamcre versus
the control mice.
SurvivinCamcre mice exhibit learning and memory defects
Adult SurvivinCamcre mice exhibited several defects that
may contribute to disorders in behavior and cognition,
including reduced SVZ-RMS-OB neurogenesis [38,39],
OB hypoplasia [40], diminution of cortical GABAergic
neurons, and seizures. We therefore evaluated the
effects of depleting NPCs of survivin by subjecting the
SurvivinCamcre and matched controls to a range of beha-
vioral studies.
There was no difference in body weight between the
SurvivinCamcre and control mice at the start of beha-
vioral testing (21.6 ± 0.6 gm versus 20.1 ± 0.6 gm for
the SurvivinCamcre and controls, respectively, p = 0.081),
and the SurvivinCamcre mice had normal visual and
Figure 6 SurvivinCamcre mice exhibit increased seizure activity. (A) Scatter plot showing the maximum seizure score assigned to each
experimental animal during a 2 hr observation period following KA administration. Seizure scores were significantly higher in the SurvivinCamcre
mice as compared to controls. Horizontal bars indicate the mean for each group. (B) KA (20 mg/kg ip) induced signficantly more severe seizure
activity in SurvivinCamcre mice as compared to controls, P < 0.001, n = 13-16 mice per group. (C, D) Representative NPY-stained coronal sections
through the hippocampus of saline-treated control (wt) (C) and SurvivinCamcre mice (ko) (D) reveals ectopic NPY expression by mossy fibers in
SurvivinCamcre mice (arrows in D). (E) Quantification of BrdU+ cells (1 day after BrdU injection) in the SGZ from saline and KA treated control and
SurvivinCamcre mice. The neurogenic response to KA was significantly dampened in SurvivinCamcre mice as compared to controls, n = 4-5 mice per
group. Results in panels B and E are reflected as means + SEM. **P < 0.001. Scale bars: C-D 500 μm.
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auditory skills, grip strength, rotarod performance, pain
response and cage activity (Additional file 1: Supplemen-
tal Figures S4, S5; Additional file 2: Supplemental Meth-
ods and Results).
In the open field test, the SurvivinCamcre mice dis-
played significant disturbances in exploratory behavior,
including delayed first entry to the center, fewer center
entries, more corner crossings, and less time in the cen-
ter (Figure 7A). This type of behavioral outcome is
often suggestive of increased anxiety, however the Survi-
vinCamcre mice performed normally in the elevated plus
maze test for anxiety. On the maze, there was no differ-
ence between control and SurvivinCamcre mice in the
total number of beam crossings (148 ± 5 versus 155 ± 9
for control and SurvivinCamcre mice respectively; n = 12
mice per group, p = 0.48), percent time spent in the
open arms (33 ± 2 versus 36 ± 4 for control and Survi-
vinCamcre mice respectively; n = 12, p = 0.76), nor per-
centage of entries into the open arms (26 ± 2 versus 23
± 3 for control and SurvivinCamcre mice respectively; n =
12, p = 0.07). The findings suggest that the poor perfor-
mance of the SurvivinCamcre mice in the open field test
may not be due to increased anxiety, but rather due to a
distinct defect in exploratory behavior.
The SurvivinCamcre mice exhibited a significant impair-
ment in passive avoidance learning. During the initial
training trial, there was no difference in step-through
latencies (12.5 ± 4.5 versus 13.9 ± 1.8 sec, SurvivinCamcre
and control mice respectively, p = 0.783). However, dur-
ing testing, the SurvivinCamcre mice demonstrated signifi-
cantly shorter latency to enter the dark compartment
than the controls (235 ± 27 versus 71 ± 24 sec for con-
trol and SurvivinCamcre mice, n = 12, p < 0.001) (Addi-
tional file 1: Supplemental Figure S6), consistent with
poor associative memory of aversive stimuli.
We examined auditory and contextual fear memory
using an auditory cue as the conditioned stimulus (CS),
and a foot shock as an aversive stimulus. Freezing times
in baseline, pre-US, post-US, and pre-CS trials were not
different between the groups (Figure 7B). However, Sur-
vivinCamcre mice exhibited significantly less freezing
response in the context and auditory cue (CS) trials
compared to control mice (context: 25.7 ± 5.5 versus
68.2 ± 4.5; auditory: 34.3 ± 9.0 and 84.4 ± 7.8, respec-
tively for SurvivinCamcre and control mice, n = 12 mice
per group, p < 0.001) (Figure 7B).
Lastly, we assessed hippocampus-dependent spatial
learning and long-term memory in the SurvivinCamcre
mice using the Morris water maze. Swimming velocity
was not different between the controls and the Survivin-
Camcre mice, excluding defects in motor ability. During
acquisition training, the SurvivinCamcre mice showed
training-dependent reduction in escape latency and path
length. However, the improvements were minimal as
compared with controls, and the escape latency and
path length were significantly increased in the Survivin-
Camcre mice (p < 0.001, n = 12; by two way repeated
measures ANOVA) (Figure 8A, B). Notably, lengths of
the escape paths were not different between the Survi-
vinCamcre mice and control mice during 4 visible-plat-
form training days (803 + 88 cm versus 1076 + 110 cm
for control, n = 10, and SurvivinCamcre mice, n = 12,
respectively; p = 0.075). These results indicate that the
SurvivinCamcre mice were fully capable and motivated to
choose the shortest pathway towards the platform in the
cued, non-spatial condition of the task.
In the first probe trial performed after 5 days of train-
ing, the control mice already had a preference for the
target quadrant compared to adjacent 1 (p = 0.002) and
opposite (p = 0.02) quadrants, whereas the Survivin-
Camcre mice had no preference at all (p = 0.46) (Figure
8C). In the second probe trial after 10 days of training,
the control mice continued to show a strong preference
for the target quadrant compared to all other quadrants
(p < 0.001), whereas the SurvivinCamcre mice equally
favoured the target and adjacent 2 quadrants (p = 0.60)
versus the other 2 quadrants (p < 0.05) (Figure 8D, E).
Since the Morris water maze test is a stress that might
alter neural cell proliferation, we also quantified the
number of Ki67+ cells in the dentate gyrus of the Survi-
vinCamcre mice (n = 4) and the corresponding littermate
controls (n = 4) after the probe trials. There was no sig-
nificant difference in the number of Ki67+ cells between
the two groups (534 + 49 cells versus 480 + 28 cells in
controls versus SurvivinCamcre mice, respectively, p =
0.378).
Overall, the SurvivinCamcre mice exhibited exploratory
behavioral abnormalities, with global deficits in various
forms of learning and memory.
Discussion
In this report, we show that survivin is prominently
expressed in the neurogenic regions of the embryonic
mouse brain, and that its expression by a subpopulation
of NPCs is maintained postnatally in the two key sites
of adult neurogenesis - the SVZ and the SGZ. Lack of
expression of survivin in the NPCs during embryonic
development, was associated with profound SVZ-RMS-
OB postnatal defects in neurogenesis and loss of inter-
neurons, manifest by major deficits in learning and
memory, and heightened sensitivity to seizures. Prenatal
administration of survivin in the brain enhanced neuro-
genesis in the SVZ-RMS-olfactory system. Our findings
position survivin as a central player in regulating neuro-
genesis during embryonic development, alterations of
which impact on postnatal brain function.
The embryonic forebrain, the telencephalon, consists
of two parts. The dorsal aspect is the origin of
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Figure 7 Open field and fear conditioning defects in SurvivinCamcre mice. (A) Open field test data are provided, with representative paths of
control (wt) and SurvivinCamcre (ko) mice. (B) Contextual and auditory-cued fear conditioning in control and SurvivinCamcre mice. Freezing times in
pre-US, post-US and pre-CS trials were not different between control and SurvivinCamcre mice. SurvivinCamcre mice showed significantly less
freezing responses as compared to controls during both the context and the auditory cue (CS) trials. US: unconditioned stimulus, shock; CS:
conditioned stimulus, auditory cue. Results in panel B are reflected as means + SEM, n = 12 mice per group. **P < 0.001.
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Figure 8 Poor performance of SurvivinCamcre mice in water maze. Morris water maze studies were performed as detailed in Methods. (A)
SurvivinCamcre mice (ko) exhibited a significantly longer escape latency as compared to controls (wt) during acquisition of the task (P < 0.001). (B)
Representative swim paths of control and SurvivinCamcre mice during acquisition training. (C) The mean percent time spent in each quadrant
during the 1st probe trial is plotted for both genotypes. In the first probe trial performed after 5 days of training, the control mice already had a
preference for the target quadrant compared to adjacent 1 and opposite quadrants, whereas the SurvivinCamcre mice had no preference at all. (D,
E) In the second probe trial (representative swim path shown in D), control mice spent most of the time in the target quadrant, while
SurvivinCamcre mice spent equal amounts of time in the target and adjacent 2 quadrant. Open triangle and black dot represent location of the
start and the platform, respectively. adj, adjacent 1 or adjacent 2 quadrant; opp, opposite quadrant. Results in panels A, C and E are reflected as
means + SEM, n = 12 mice per group. *P < 0.05; **P < 0.001.
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glutamatergic excitatory neurons of the cerebral cortex
and hippocampus [41]. The ventral part, comprising the
ganglionic eminences, gives rise to the basal ganglia.
The LGE provides neurons for the striatum [42], inter-
neurons of the olfactory bulb (OB) [43], and most adult
SVZ NPCs [2]. The MGE is the source of most neocor-
tical [42] and hippocampal interneurons [44], as well as
striatal interneurons. At E12.5, survivin is widely
expressed in the neurogenic region of the ventral and
dorsal telencephalon. Since cre recombinase expression
in the CamKIIa-cre mice is low in the dorsal telence-
phalon, generation of principal glutamatergic neurons
was largely unaffected in the adult, and the overall
integrity of the hippocampus and cortex was main-
tained, albeit the latter was thinner. In contrast, the
number of cortical GABAergic neurons, which arise pri-
marily in the ganglionic eminences and comprise 25-
30% of cortical neurons, was significantly reduced in the
SurvivinCamcre mice. This reduction may have been
further contributed to by the paucity of SVZ NPCs,
recently shown to be a continuous postnatal source of
GABAergic interneurons in the cortex [45].
Imbalances in inhibitory and excitatory circuits due to
decreases in numbers of interneurons, are well known
to be associated with seizures in humans and experi-
mental animal models [46,47]. This was clearly evident
in the SurvivinCamcre mice which, even under naïve con-
ditions, displayed spontaneous, generalized tonic-clonic
motor seizures, a phenotype that was more dramatically
revealed following challenge with KA. Indeed, Survivin-
Camcre mice showed a rapid and consistent generalization
of seizures at KA doses that normally result in focal hip-
pocampal epileptic activity [48]. Thus, a defect in the
cortical inhibitory system may explain the higher sus-
ceptibility to generalized convulsions in the Survivin-
Camcre mice.
Our studies demonstrate that the loss of a subpopula-
tion of NPCs in the SVZ of neonatal and adult Survivin-
Camcre mice, with resultant near-absence of the RMS and
OB, was due to a combination of increased apoptosis
and decreased cellular proliferation of NPCs in the cor-
responding embryonic neurogenic region (ganglionic
eminences). Indeed, this is in line with the fact that sur-
vivin is a pro-survival molecule with the capacity to
inhibit apoptosis and to promote the cell cycle and
mitosis (reviewed in [49]). Somewhat surprisingly, in
spite of profound disturbances in neurogenesis in the
SVZ, we did not detect baseline changes in neurogenesis
in the SGZ of the DG in the SurvivinCamcre mice, or sig-
nificant loss of survivin expressing DG NPCs. Although
this may be due to cre recombinase inefficiency, the
finding may also be due to the embryonic origin of SGZ
NPCs being different from the SVZ NPCs, which still
remains to be clarified [50]. There is however, a defect
in SGZ neurogenesis in the SurvivinCamcre mice that is
only evident under stress conditions. This may mean
that the baseline source(s) of SGZ NPCs is different
from that recruited during stress, an hypothesis that
requires testing. In the SurvivinCamcre mice, the neuro-
genic response was significantly impaired as compared
to the controls after KA-induced seizures. Alterations in
GABA signaling in the SurvivinCamcre mice may be
implicated [51], but other factors that are important in
maintaining the function of the neurogenic niche in the
hippocampus could also contribute to the dampened
response [52]. Further study to identify those that are
relevant is ongoing.
Although the integrity of the hippocampus was appar-
ently maintained under baseline conditions, upon test-
ing, the SurvivinCamcre mice exhibited striking defects in
memory and cognition, that are consistent with hippo-
campal dysfunction. In fact, the behavioral abnormalities
were associated with a significant impairment of long-
term potentiation (LTP) in the CA1 region of the hippo-
campus (not shown), a finding that frequently is asso-
ciated with poor memory, and often with increased
epileptic activity. As with the seizure disorder, a loss of
cortical inhibitory interneurons likely contributed to the
behavioral abnormalities and cognitive defects in the
SurvivinCamcre mice. We also cannot exclude a contribu-
tion of suboptimal neurogenic responses to the beha-
vioral phenotype, as neurogenic defects in both the SGZ
and SVZ have been implicated in memory, cognition,
mood, and hippocampal-dependent learning [53]. More-
over, olfactory bulbectomy in rodents impairs neurogen-
esis in both the SGZ and the SVZ, disrupts normal
hippocampal LTP, and causes significant deficits in
learning and memory. Thus, the OB, which sends pro-
jections to the hippocampus [54], also plays a role in
normal behavior and cognition [12,13,40]. Indeed, since
the SurvivinCamcre mice have major defects in neurogen-
esis, as well as notable hypoplasia of the OB, all of
which are associated with epileptic activity and major
alterations in behavior, it is reasonable to consider that
the effective lack of an OB exacerbates the loss of SVZ
and possibly SGZ NPCs, which in turn, contributes to
the behavioral abnormalities and enhanced seizure
activity.
Conclusions
We have established that prenatal expression of survivin
in neurogenic regions of the developing brain plays a
key role in learning and memory and in determining sei-
zure susceptibility. Prenatal stresses are recognized to
suppress postnatal neurogenesis that in turn, induces
behavioral abnormalities in the neonate and adult [8,9].
While the underlying molecular mechanisms have not
been delineated, it is reasonable to consider that
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alterations in embryonic NPC survivin expression might
contribute to those phenotypic changes. Pilot data indi-
cate that prenatal administration of survivin can
enhance neurogenesis in the olfactory system. We do
not yet know whether the resultant new neurons differ-
entiate or integrate, or whether the SGZ is also affected.
Nonetheless, the findings are promising, supporting the
critical nature of this molecule, and its potential as a
therapeutic target. Our mouse model provides the
opportunity to elucidate the relevance of survivin-
expressing NPC subpopulations in vivo in response to a
range of environmental stresses, and genetic or epige-
netic factors.
Methods
Transgenic mice and genotyping
Mice that express Cre recombinase driven by the pro-
moter of the gene for calmodulin-dependent protein
kinase IIa (CamKIIa) [30,31] (gift of Dr. G. Schütz, Hei-
delberg, Germany) were bred with mice in which the
survivin gene is flanked by loxP sites [32]. The resulting
offspring that were heterozygous for Cre and homozy-
gous for floxed survivin (Survivinlox/lox) (hereafter
referred to as SurvivinCamcre mice) were compared to lit-
termate control mice which did not express Cre and
were Survivinlox/lox. Survivinlox/lox embryos and adults
were not different from Survivinlox/wt, Survivinwt/wt or
CamKIIa-cre:survivinlox/wt mice. Mice were maintained
on a C57B/6:Swiss:129svj 75:12.5:12.5 background. Gen-
otyping of tail DNA was performed by PCR as pre-
viously reported [30,32]. Mice were group-housed in
standard mouse cages in a room with a 12 h light-dark
cycle and ad libitum access to food and water and all
animal experiments were approved by the ethics com-
mittee of the University of Leuven.
BrdU labeling and quantification
Adult mice and pregnant females were injected intraper-
itoneally (ip) with 5-bromo-2-deoxyuridine (BrdU,
Sigma Aldrich, Bornem, Belgium) at a concentration of
50 mg per kg body weight. For the analysis of the
embryos, 1 hour after injection of BrdU, pregnant
females were killed by cervical dislocation, after which
the embryos were harvested, placed in ice-cold PBS, and
then fixed in 4% paraformaldehyde (Para) for cutting 20
μm cryo sections using a microtome/cryostat (HM550,
Microm, Walldorf, Germany). For analysis of adults,
mice were anesthetized with sodium pentobarbital at 1
hour (unless stated otherwise) after BrdU and perfused
transcardially with 0.9% NaCl, followed by fixation with
4% paraformaldehyde. Brains were dissected and post-
fixed overnight at 4°C and 40 μm tissue sections were
prepared using a vibrating microtome (HM650V,
Microm, Walldorf, Germany).
The number of BrdU+ cells in the adult dentate gyrus
(DG) was quantified using a modified version of the
optical fractionator method [55] with Stereo Investigator
software (MicroBrightField, Colchester, VT, USA). Cells
were counted with a 40× objective on every sixth sec-
tion through the entire rostrocaudal extension of one
half of the DG, restricted to the subgranular zone (SGZ)
[56]. The number of BrdU+ cells in the SVZ of one lat-
eral ventricle was counted with a 40× objective on 1
coronal section (bregma level + 0.14 mm) per animal.
Immunohistochemistry
Immunostaining protocols were optimized for the differ-
ent tissue preparations and antibodies. In general, tissue
sections were treated with 1% H202 in PBS/methanol for
15 min, incubated in 5% serum for 30 min, and incu-
bated overnight at 4°C in following primary antibodies:
rabbit anti-neuropeptide Y (NPY) antibody (1:5000,
Bachem, UK); mouse anti-NeuN (1:500, Chemicon, Hof-
heim, Germany); mouse anti-PCNA (1:1000, Chemicon,
Hofheim, Germany); rabbit anti-DCX (1:500, Cell Sig-
naling, MA, USA); rat anti-BrdU (1:500, Immunologicals
Direct, Oxford, UK); chicken anti-GFP (1:3000, Aves,
Oregon, USA); and rabbit anti-Cre recombinase (1:3000,
gift from Dr. Schütz, Heidelberg, Germany); rabbit anti-
Ki67 (1:1000 Monosan, Uden, The Netherlands). After
washes, the corresponding biotinylated secondary anti-
body was added for 1 hour and the signal was amplified
using the Vectastain Elite ABC kit (Vector Laboratories,
CA, USA). Peroxidase activity was detected with 3,3’-
diaminobenzidine (DAB peroxidase substrate tablet set,
Sigma Aldrich, Bornem, Belgium). For fluorescent stain-
ing, Alexa-conjugated secondary antibodies (Molecular
Probes, Leiden, The Netherlands) were used. BrdU
staining was performed as reported previously [57].
In situ hybridization
Digoxygenin (DIG)-labeled RNA probes for Dlx1 [58],
Dlx5 [24], Ngn2 (gift from Dr. A. Simeone), GAD65
[59], GAD67AE [60] and vGLUT1 (Allen Institute for
Brain Science) were generated using the DIG RNA
Labeling Kit (Roche Diagnostics, Basel, Switzerland),
according to the manufacturer’s instructions. GAD65
and GAD67AE probes were mixed to detect the total
number of GABAergic interneurons. For survivin ribop-
robes, full-length murine survivin cDNA was cloned
into the pcDNA3 plasmid vector (Invitrogen, CA, USA)
[61], and linearized for generation of antisense and
sense probes using Sp6 RNA polymerase or T7 poly-
merase, respectively. In situ hybridization and combined
immunohistochemistry protocols were adapted from
those reported [33,62] and completed on 20 μm cryostat
or 40 μm vibratome sections.
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Measurement of granular cell layer (GCL) volume and
hilar volume
Coronal sections through the DG were stained with cre-
syl violet. Pictures were taken at 4× magnification, and
the area of the GCL and the hilus was determined off
line using Metamorph software (Molecular Devices,
Sunnyvale, CA). Volumes were calculated and expressed
in mm3.
Quantification of apoptosis (tunel+ cells)
Detection of cellular apoptosis in 10 μm coronal paraffin
sections, prepared using a HM360 microtome (Microm,
Walldorf, Germany), was accomplished using the Apop-
Tag Peroxidase In Situ Apoptosis Detection Kit (Chemi-
con, Hofheim, Germany). The number of tunel+ cells
was counted with a 40× objective. The anterior subven-
tricular zone (SVZa) was analyzed at level bregma +0.98
mm and the data are presented as the number of tunel+
cells per 100 nucleated cells. The subgranular zone
(SGZ) was analyzed at bregma levels -1.34/-1.70/-2.46/-
2.80 mm and the data are presented as the number of
tunel+ cells per section.
Quantification of inhibitory and excitatory neurons
Numbers of neurons and interneurons were quantified
hemilaterally on coronal vibratome sections at 4 bregma
levels (-1.34/-1.70/-2.46/-2.8 mm). GAD65/67+ cells
were counted with a 10× objective in the hilus plus the
granule cell layer, and in the parieto/temporal cortex, in
a 1.4 mm wide band from the white matter to the pial
surface. vGLUT1+ cells in the parieto/temporal cortex
were counted with a 20× objective in a 0.7 mm wide
band. NPY+ cells in the hilus were counted with a 20×
objective on every sixth section (40 μm thick). Results
are presented as the number of cells per mm2.
Quantification of Ki67 positive cells
Ki67 positive cells in the SGZ were counted hemilater-
ally with a 40× objective on every third 40 μm section
between bregma levels -1.34 and -2.8 mm. The number
of counted cells was multiplied by 3 to obtain the total
number of Ki67 positive cells.
Intracerebroventricular (ICV) injection of lentiviral vector
in embryos
Lentiviral vectors were prepared, encoding enhanced
green fluorescent protein (eGFP) and survivin separated
by a T2A sequence starting from pCHMWS-eGFP-T2A-
Fluc (gift from Dr. V. Baekelandt, KULeuven). The Fluc
fragment was removed from pCHMWS-eGFP-T2A-Fluc
using BamHI and MluI and replaced by the cDNA
encoding full-length murine survivin. Survivin expres-
sion from this vector was confirmed by Western blot
analysis of lysates from transfected COS cells. Human
immunodeficiency virus type 1 (HIV-1)-derived lentiviral
vectors were produced by a standard protocol. The viral
vector was mixed with Fast Green dye (0.005% final
concentration, Sigma-Aldrich, Bornem, Belgium), which
allowed visualization of the distribution of the viral vec-
tor in the cerebral ventricles after injection. Pregnant
mice (stage E12.5) were anesthetized with 50 mg/ml
ketamine, 2% xylazine in saline and placed supine on a
heating pad. A 2-cm midline incision was made through
the skin and the abdominal wall. The uterine horn was
drawn out through the hole onto gauze, and with the
uterus transilluminated, a 35 gauge needle (beveled
NanoFil needle, World Precision Instruments, FL, USA)
was inserted into the ventricle, and 1 μl viral vector
solution was injected at a speed of 406 nanoliters per
second using a Mycro4® MicroSyringe Pump Controller
(World Precision Instruments, FL, USA).
Seizure studies
Seizures in adult male mice were evoked by ip adminis-
tration of kainic acid (KA) (Sigma, MO, USA). KA was
dissolved in saline and injected at 20 or 30 mg/kg body
weight. Saline-injected animals were used as controls.
Seizure severity was quantified by an observer blind to
the mouse genotype using the following scale [48,63]:
stage 0, normal behavior; stage 1, immobility; stage 2,
forelimb and/or tail extension, rigid posture; stage 3,
repetitive movements, head bobbing; stage 4, rearing
and falling; stage 5, continuous rearing and falling; stage
6, severe whole-body convulsions; and stage 7, death.
For each animal, seizure severity was scored every 10
min over a period of 2 hours after KA administration.
The maximum score reached by each animal over the
entire observation period was used to calculate the max-
imum seizure score for each treatment group. Seizure
severity over the 2 hour observation period was calcu-
lated for each mouse as the area under the seizure score
versus time curve (AUC), and the average AUC was cal-
culated for each treatment group.
Behavioral studies
Behavioral tests were initiated when the mice were 3-4
months of age, n = 12-25 per group. Neuromotor,
exploration, and learning tests were performed in the
following sequence: cage activity, grip strength, rotarod,
open field, elevated plus maze, Morris water maze, pas-
sive avoidance. Contextual fear conditioning was per-
formed on a separate group of mice. Animals were
tested during the light phase of the light-dark cycle. All
studies were performed by observers who were blinded
to the genotype of the mice.
Open field exploratory activity was assessed in a 50
cm × 50 cm arena using EthoVision video tracking and
software (Noldus, Wageningen, The Netherlands). Mice
were individually placed in a specific corner of the open
field, and were allowed a 1 min adaptation period. The
path was recorded for 10 min to measure dwells and
entries in different parts of the field. Measures included
total path length, percentage path length in the center
circle (diameter 30 cm), entries into the four corner
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squares, entries into the center, time spent in the center
versus periphery, latency of first center approach, and
frequency of rearing.
The elevated plus maze [64,65], to evaluate anxiety-
like behavior, had two open arms (21 cm × 5 cm) and
two closed arms of the same size, with high side walls,
and was raised 30 cm above the table. Each mouse was
placed in the central square of the maze, facing one of
the closed arms. After 1 min, exploratory behavior was
recorded automatically during a 10 min period using
five infrared beams, connected to an activity logger. For
each mouse, the number of arm entries, percentage of
open arm entries, and percentage time spent in the
open arms was assessed.
Passive avoidance (aversive) learning [66] was tested in
a two-compartment step-through box. Animals were
adapted to the dark for 30 min, and then placed into a
small illuminated compartment. After 5 s, a sliding door
leading to the large dark compartment was opened.
Upon entry, the door was closed and the animal
received an electric foot shock (0.3 mA, 1s). Twenty-
four hours later, the animals were placed again in the
light compartment and the latency to enter the dark
compartment was measured up to 300 s, to evaluate
memory of the foot shock.
Contextual and auditory-cued fear conditioning
[67,68] was tested in a Plexiglas chamber with a grid
floor through which a foot shock could be administered.
Mice were trained and tested on 3 consecutive days: On
the day 1, the mice were individually placed in the test-
ing chamber and allowed to adapt for 5 min. On the
day 2, the animals were allowed to explore the testing
chamber for 2 min, after which an auditory cue (condi-
tioned stimulus, CS) was presented for 28 s, followed by
a foot shock (0.3 mA, 2 s; unconditioned stimulus, US).
The time (%) spent freezing during the first 2 min and
28 s is the pre-US score. The mice were then allowed to
explore again for 1 min, and the auditory cue and shock
were again presented, followed by another 2 min
exploration (post-US score). On day 3 (24 hours after
training), mice were returned to the same context in
which training occurred, and freezing behavior was
recorded for 5 min (context test). Ninety min later,
freezing was recorded in a novel environment (the grid
floor was hidden and a scent of peppermint was added)
for 3 min without the auditory cue stimulus (pre-CS
test). Finally, the auditory cue was turned on, and the
time spent freezing was recorded over the following 3
min (cue CS test).
Spatial learning and memory were examined in a
Morris water maze [69,70], which consisted of a circular
tank (32.5 cm high × 150 cm diameter), filled with
water (up to 16 cm deep), maintained at 26°C, and
made opaque with nontoxic white paint. A circular
platform (15 cm high × 15 cm diameter) remained hid-
den 1 cm below the water surface at a fixed position.
The room housing the tank had a permanent display of
distal extra-maze cues. The swim paths of the mice
were recorded using computerized EthoVision video
tracking equipment. During training (acquisition phase),
the mice were given four swim trials daily with an inter-
trial interval of 15 min. The mice were placed in the
pool facing the wall at one of four starting positions. If
the animal did not find the platform after 120 s, it was
guided there by the experimenter. Mice were allowed to
rest 15 s on the platform before being removed from
the pool. Latency to reach the platform, path length,
and average swim speed were recorded. After five train-
ing days, there were two days of rest, followed by
another five days of training and two days of rest. Probe
trials were performed on days 8 and 15. During probe
trials, the platform was removed and each animal was
monitored once for 100 s, recording the percentage
time in each quadrant. Over all the trials, one Survivin-
Camcre mouse floated with a speed of < 5 cm/s, and this
mouse was therefore excluded from the study.
Statistical analyses
Data are presented as the mean ± SEM. Data were ana-
lyzed with a two tailed t-test, Mann-Whitney Rank Sum
Test, one way ANOVA, or two way repeated measures
ANOVA. All statistical tests were performed at a signifi-
cance level of 0.05.
Additional file 1: Supplemental Figures S1-S6. Supplemental Figure
S1: CAMKIIa-cre activity in neurogenic regions of embryo. CAMKIIa-
cre recombinase activity in the embryonic brain was checked by
breeding CAMKIIa-cre mice with ROSA26-stop-YFP reporter mice. GFP
stained coronal section through the ganglionic eminence and dorsal
telencephalon of E12.5 CAMKIIa-cre+/-:ROSA26-stop-YFP/wt mice reveals
prominent CAM-cre activity in the ganglionic eminences, but less in the
dorsal telencephalon. Survivin mRNA expression is shown in adjacent
section. Scale bars 500 μm. HP, hippocampus; GE, ganglionic eminence;
NCX, neocortex. Supplemental Figure S2: CAMKIIa-cre is not
expressed in SGZ or SVZ postnatally. Sagittal sections through the
dentate gyrus (A, C-E) and lateral ventricle (B, F-H) of CAMKIIa-cre+/-
adult mouse brain (6 weeks). (A, B) Staining for cre recombinase (red)
and DAPI nuclear staining (blue) shows that cre expression is present in
the dentate granule cell layer (GCL), the striatum (ST) and the cortex
(CTX). Lack of red staining of DAPI+ nuclei in the SGZ and SVZ/RMS
confirms that CAMKIIa-cre is not expressed in the SGZ or SVZ NPCs
postnatally. Double stainining of the dentate gyrus (C-E) and the SVZ (F-
H) for cre recombinase (red) and mature neuronal marker NeuN (green),
with overlay of fields (E and H), confirms that CAMKIIa-cre expression
colocalizes 100% with NeuN and is not present in SGZ or SVZ NPCs. LV,
lateral ventricle. Supplemental Figure S3: Exogenous gene delivery of
survivin in embryonic NPCs may increase OB neurogenesis. GFP
labeling of sagittal sections through the olfactory bulb (OB) of P21
control (A, B) and SurvivinCamcre (ko) (C, D) mice that were injected in the
cerebral ventricle at E12.5 with control-GFP (A, C) or survivin-GFP (B, D)
lentiviral vector. Injection of survivin results in an increased number of
embryonic NPC-derived cells in the OB. Scale bars: 500 μm.
Supplemental Figure S4: Cage activity recordings. Cage activity was
recorded at 30 min intervals over 23 hours, monitoring the number of
laser beam crossings by each mouse (n = 12 per group). There were no
significant differences between control (wt) and SurvivinCamcre (ko) mice
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in the total number of beam crossings (p = 0.40) and no alterations in
circadian activity profiles (p = 0.30). Results reflect means + SEM.
Supplemental Figure S5: Visual evoked potentials. Visual evoked
potentail (VEP) recordings from control (wt) and SurvivinCamcre (ko) mice,
reveal similar peak latency and amplitude for both genotypes.
Supplemental Figure S6: Passive avoidance studies. The SurvivinCamcre
mice (ko) exhibited a significant impairment in passive avoidance
learning, indicated by their shorter latency to enter the dark
compartment than the controls (wt).
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2202-11-2-
S1.PPTX ]
Additional file 2: Supplemental Methods and Results. Additional
methods and results
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2202-11-2-
S2.rtf ]
Acknowledgements
This work was supported in part by the Fonds voor Wetenschappelijk
Onderzoek (FWO), Belgium. YB was supported by grants from Parents
Against Childhood Epilepsy (PACE, Inc.), NY, USA, and the Italian National
Research Council (CNR - “Ricerche Spontanee a Tema Libero” - RSTL
Program).
Author details
1KU Leuven, VIB Vesalius Research Center (VRC), Herestraat 49, Gasthuisberg
ON1, B3000 Leuven, Belgium. 2KU Leuven Laboratory of Biological
Psychology, Tiensestraat 102, B3000 Leuven, Belgium. 3Dept of
Pharmacology, University of Milan, via Vanvitelli 32, Milan, Italy. 4Istituto di
Neuroscienze, Consiglio Nazionale delle Ricerche, via G. Moruzzi 1, 56100
Pisa, Italy. 5KU Leuven, Laboratory for Neurobiology and Gene Therapy,
Kapucijnenvoer 33, B3000 Leuven, Belgium. 6Developmental Biology Institute
of Marseille, NMDA CNRS, INSERM, Univ. de Mediterranee, Campus de
Luminy, 13288 Marseille, France. 7Department of Psychiatry, University of
Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, Texas,
75390-9070 USA. 8Department of Cellular and Molecular Medicine
Neuroscience Program, University of Ottawa, 451 Smyth Road, Ottawa, K1H
8M5 Canada. 9Laboratory of Molecular Neuropathology, Centre for
Integrative Biology, University of Trento, via delle Regole 101, 38060 Trento,
Italy. 10Center for Blood Research, Faculty of Medicine, University of British
Columbia, 2350 Health Sciences Mall, Vancouver, V6T 1Z3 Canada.
Authors’ contributions
VC was involved in designing and performing all experiments. VC, DL, AE,
RD’H, UB, MC, VB and HC helped in drafting the manuscript. VC, VR, AD, JC,
MM and TJ prepared riboprobes, did cDNA cloning and sequencing, in situ
hybridizations, in vivo studies, histologic sectioning, acquisition of data and
analyses. TA, DB, RD’H helped in behavioral studies. FA, YB, MC helped in
seizure studies. AE and DL provided continuous intellectual input, evaluation
and interpretation of data. EC conceived, designed and co-ordinated the
project, and drafted the manuscript. All authors read and approved the final
manuscript.
Received: 24 July 2009
Accepted: 5 January 2010 Published: 5 January 2010
References
1. Zhao C, Deng W, Gage FH: Mechanisms and functional implications of
adult neurogenesis. Cell 2008, 132:645-660.
2. Young KM, Fogarty M, Kessaris N, Richardson WD: Subventricular zone
stem cells are heterogeneous with respect to their embryonic origins
and neurogenic fates in the adult olfactory bulb. J Neurosci 2007,
27:8286-8296.
3. Luskin MB: Restricted proliferation and migration of postnatally
generated neurons derived from the forebrain subventricular zone.
Neuron 1993, 11:173-189.
4. Cameron HA, Woolley CS, McEwen BS, Gould E: Differentiation of newly
born neurons and glia in the dentate gyrus of the adult rat. Neuroscience
1993, 56:337-344.
5. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O: Neuronal replacement
from endogenous precursors in the adult brain after stroke. Nat Med
2002, 8:963-970.
6. van Praag H, Schinder AF, Christie BR, Toni N, Palmer TD, Gage FH:
Functional neurogenesis in the adult hippocampus. Nature 2002,
415:1030-1034.
7. Carlen M, Cassidy RM, Brismar H, Smith GA, Enquist LW, Frisen J: Functional
integration of adult-born neurons. Curr Biol 2002, 12:606-608.
8. Lemaire V, Koehl M, Le Moal M, Abrous DN: Prenatal stress produces
learning deficits associated with an inhibition of neurogenesis in the
hippocampus. Proc Natl Acad Sci USA 2000, 97:11032-11037.
9. Lucassen PJ, Bosch OJ, Jousma E, Kromer SA, Andrew R, Seckl JR,
Neumann ID: Prenatal stress reduces postnatal neurogenesis in rats
selectively bred for high, but not low, anxiety: possible key role of
placental 11beta-hydroxysteroid dehydrogenase type 2. The European
journal of neuroscience 2009, 29:97-103.
10. Gould E, Beylin A, Tanapat P, Reeves A, Shors TJ: Learning enhances adult
neurogenesis in the hippocampal formation. Nat Neurosci 1999, 2:260-
265.
11. Keilhoff G, Becker A, Grecksch G, Bernstein HG, Wolf G: Cell proliferation is
influenced by bulbectomy and normalized by imipramine treatment in a
region-specific manner. Neuropsychopharmacology 2006, 31:1165-1176.
12. Hozumi S, Nakagawasai O, Tan-No K, Niijima F, Yamadera F, Murata A,
Arai Y, Yasuhara H, Tadano T: Characteristics of changes in cholinergic
function and impairment of learning and memory-related behavior
induced by olfactory bulbectomy. Behavioural brain research 2003, 138:9-
15.
13. Han F, Shioda N, Moriguchi S, Qin ZH, Fukunaga K: The vanadium (IV)
compound rescues septo-hippocampal cholinergic neurons from
neurodegeneration in olfactory bulbectomized mice. Neuroscience 2008,
151:671-679.
14. Parent JM: Injury-induced neurogenesis in the adult mammalian brain.
Neuroscientist 2003, 9:261-272.
15. Hattiangady B, Shetty AK: Implications of decreased hippocampal
neurogenesis in chronic temporal lobe epilepsy. Epilepsia 2008, 49(Suppl
5):26-41.
16. Hagg T: From neurotransmitters to neurotrophic factors to neurogenesis.
Neuroscientist 2009, 15:20-27.
17. Trujillo CA, Schwindt TT, Martins AH, Alves JM, Mello LE, Ulrich H: Novel
perspectives of neural stem cell differentiation: from neurotransmitters
to therapeutics. Cytometry A 2009, 75:38-53.
18. Mattson MP: Glutamate and neurotrophic factors in neuronal plasticity
and disease. Annals of the New York Academy of Sciences 2008, 1144:97-
112.
19. Ihrie RA, Alvarez-Buylla A: Cells in the astroglial lineage are neural stem
cells. Cell and tissue research 2008, 331:179-191.
20. Li F, Ling X: Survivin study: an update of “what is the next wave"?.
Journal of cellular physiology 2006, 208:476-486.
21. Altieri DC: New wirings in the survivin networks. Oncogene 2008, 27:6276-
6284.
22. Adida C, Crotty P, McGrath J, Berrebi D, Diebold J, Altieri D:
Developmentally regulated expression of the novel cancer anti-
apoptosis gene survivin in human and mouse differentiation. Am J Path
1998, 152:43-49.
23. Jiang Y, de Bruin A, Caldas H, Fangusaro J, Hayes J, Conway EM,
Robinson M, Altura RA: Essential role for survivin in early brain
development. J Neurosci 2005, 25:6962-6970.
24. Zerucha T, Stuhmer T, Hatch G, Park BK, Long Q, Yu G, Gambarotta A,
Schultz JR, Rubenstein JL, Ekker M: A highly conserved enhancer in the
Dlx5/Dlx6 intergenic region is the site of cross-regulatory interactions
between Dlx genes in the embryonic forebrain. J Neurosci 2000, 20:709-
721.
25. Kele J, Simplicio N, Ferri AL, Mira H, Guillemot F, Arenas E, Ang SL:
Neurogenin 2 is required for the development of ventral midbrain
dopaminergic neurons. Development 2006, 133:495-505.
26. Panganiban G, Rubenstein JL: Developmental functions of the Distal-less/
Dlx homeobox genes. Development 2002, 129:4371-4386.
Coremans et al. BMC Neuroscience 2010, 11:2
http://www.biomedcentral.com/1471-2202/11/2
Page 17 of 19
27. Pennartz S, Belvindrah R, Tomiuk S, Zimmer C, Hofmann K, Conradt M,
Bosio A, Cremer H: Purification of neuronal precursors from the adult
mouse brain: comprehensive gene expression analysis provides new
insights into the control of cell migration, differentiation, and
homeostasis. Molecular and cellular neurosciences 2004, 25:692-706.
28. Gleeson JG, Lin PT, Flanagan LA, Walsh CA: Doublecortin is a microtubule-
associated protein and is expressed widely by migrating neurons.
Neuron 1999, 23:257-271.
29. Mullen RJ, Buck CR, Smith AM: NeuN, a neuronal specific nuclear protein
in vertebrates. Development 1992, 116:201-211.
30. Casanova E, Fehsenfeld S, Mantamadiotis T, Lemberger T, Greiner E,
Stewart AF, Schutz G: A CamKIIalpha iCre BAC allows brain-specific gene
inactivation. Genesis 2001, 31:37-42.
31. Belz T, Liu HK, Bock D, Takacs A, Vogt M, Wintermantel T, Brandwein C,
Gass P, Greiner E, Schutz G: Inactivation of the gene for the nuclear
receptor tailless in the brain preserving its function in the eye. The
European journal of neuroscience 2007, 26:2222-2227.
32. Xing Z, Conway EM, Kang C, Winoto A: Essential role of survivin, an
inhibitor of apoptosis protein, in T cell development, maturation, and
homeostasis. J Exp Med 2004, 199:69-80.
33. Zimmer C, Tiveron MC, Bodmer R, Cremer H: Dynamics of Cux2 expression
suggests that an early pool of SVZ precursors is fated to become upper
cortical layer neurons. Cereb Cortex 2004, 14:1408-1420.
34. David A, Tiveron MC, Defays A, Beclin C, Camosseto V, Gatti E, Cremer H,
Pierre P: BAD-LAMP defines a subset of early endocytic organelles in
subpopulations of cortical projection neurons. Journal of cell science 2007,
120:353-365.
35. Lin JH, Saito T, Anderson DJ, Lance-Jones C, Jessell TM, Arber S:
Functionally related motor neuron pool and muscle sensory afferent
subtypes defined by coordinate ETS gene expression. Cell 1998, 95:393-
407.
36. Sorensen AT, Nikitidou L, Ledri M, Lin EJ, During MJ, Kanter-Schlifke I,
Kokaia M: Hippocampal NPY gene transfer attenuates seizures without
affecting epilepsy-induced impairment of LTP. Experimental neurology
2008, 215(2):328-33, 2009.
37. Sperk G, Hamilton T, Colmers WF: Neuropeptide Y in the dentate gyrus.
Progress in brain research 2007, 163:285-297.
38. Kempermann G, Brandon EP, Gage FH: Environmental stimulation of 129/
SvJ mice causes increased cell proliferation and neurogenesis in the
adult dentate gyrus. Curr Biol 1998, 8:939-942.
39. Snyder JS, Hong NS, McDonald RJ, Wojtowicz JM: A role for adult
neurogenesis in spatial long-term memory. Neuroscience 2005, 130:843-
852.
40. Jaako-Movits K, Zharkovsky A: Impaired fear memory and decreased
hippocampal neurogenesis following olfactory bulbectomy in rats. The
European journal of neuroscience 2005, 22:2871-2878.
41. Kriegstein AR, Noctor SC: Patterns of neuronal migration in the
embryonic cortex. Trends in neurosciences 2004, 27:392-399.
42. Wichterle H, Turnbull DH, Nery S, Fishell G, Alvarez-Buylla A: In utero fate
mapping reveals distinct migratory pathways and fates of neurons born
in the mammalian basal forebrain. Development 2001, 128:3759-3771.
43. Wichterle H, Garcia-Verdugo JM, Herrera DG, Alvarez-Buylla A: Young
neurons from medial ganglionic eminence disperse in adult and
embryonic brain. Nat Neurosci 1999, 2:461-466.
44. Pleasure SJ, Anderson S, Hevner R, Bagri A, Marin O, Lowenstein DH,
Rubenstein JL: Cell migration from the ganglionic eminences is required
for the development of hippocampal GABAergic interneurons. Neuron
2000, 28:727-740.
45. Inta D, Alfonso J, von Engelhardt J, Kreuzberg MM, Meyer AH, van Hooft JA,
Monyer H: Neurogenesis and widespread forebrain migration of distinct
GABAergic neurons from the postnatal subventricular zone. Proc Natl
Acad Sci USA 2008, 105:20994-20999.
46. Cobos I, Calcagnotto ME, Vilaythong AJ, Thwin MT, Noebels JL, Baraban SC,
Rubenstein JL: Mice lacking Dlx1 show subtype-specific loss of
interneurons, reduced inhibition and epilepsy. Nat Neurosci 2005, 8:1059-
1068.
47. Gant JC, Thibault O, Blalock EM, Yang J, Bachstetter A, Kotick J,
Schauwecker PE, Hauser KF, Smith GM, Mervis R, Li Y, Barnes GN:
Decreased number of interneurons and increased seizures in neuropilin
2 deficient mice: Implications for autism and epilepsy. Epilepsia 2008,
50(4):629-45, 2009.
48. Bozzi Y, Vallone D, Borrelli E: Neuroprotective role of dopamine against
hippocampal cell death. J Neurosci 2000, 20:8643-8649.
49. Mita AC, Mita MM, Nawrocki ST, Giles FJ: Survivin: key regulator of mitosis
and apoptosis and novel target for cancer therapeutics. Clin Cancer Res
2008, 14:5000-5005.
50. Seri B, Garcia-Verdugo JM, Collado-Morente L, McEwen BS, Alvarez-Buylla A:
Cell types, lineage, and architecture of the germinal zone in the adult
dentate gyrus. The Journal of comparative neurology 2004, 478:359-378.
51. Ge S, Pradhan DA, Ming GL, Song H: GABA sets the tempo for activity-
dependent adult neurogenesis. Trends in neurosciences 2007, 30:1-8.
52. Balu DT, Lucki I: Adult hippocampal neurogenesis: regulation, functional
implications, and contribution to disease pathology. Neuroscience and
biobehavioral reviews 2009, 33:232-252.
53. Imayoshi I, Sakamoto M, Ohtsuka T, Takao K, Miyakawa T, Yamaguchi M,
Mori K, Ikeda T, Itohara S, Kageyama R: Roles of continuous neurogenesis
in the structural and functional integrity of the adult forebrain. Nat
Neurosci 2008, 11:1153-1161.
54. Dusek JA, Eichenbaum H: The hippocampus and memory for orderly
stimulus relations. Proc Natl Acad Sci USA 1997, 94:7109-7114.
55. Rossi C, Angelucci A, Costantin L, Braschi C, Mazzantini M, Babbini F,
Fabbri ME, Tessarollo L, Maffei L, Berardi N, Caleo M: Brain-derived
neurotrophic factor (BDNF) is required for the enhancement of
hippocampal neurogenesis following environmental enrichment. The
European journal of neuroscience 2006, 24:1850-1856.
56. Mandyam CD, Harburg GC, Eisch AJ: Determination of key aspects of
precursor cell proliferation, cell cycle length and kinetics in the adult
mouse subgranular zone. Neuroscience 2007, 146:108-122.
57. Schanzer A, Wachs FP, Wilhelm D, Acker T, Cooper-Kuhn C, Beck H,
Winkler J, Aigner L, Plate KH, Kuhn HG: Direct stimulation of adult neural
stem cells in vitro and neurogenesis in vivo by vascular endothelial
growth factor. Brain Pathol 2004, 14:237-248.
58. Simeone A, Acampora D, Pannese M, D’Esposito M, Stornaiuolo A,
Gulisano M, Mallamaci A, Kastury K, Druck T, Huebner K, et al: Cloning and
characterization of two members of the vertebrate Dlx gene family. Proc
Natl Acad Sci USA 1994, 91:2250-2254.
59. Wuenschell CW, Fisher RS, Kaufman DL, Tobin AJ: In situ hybridization to
localize mRNA encoding the neurotransmitter synthetic enzyme
glutamate decarboxylase in mouse cerebellum. Proc Natl Acad Sci USA
1986, 83:6193-6197.
60. Szabo G, Kartarova Z, Hoertnagl B, Somogyi R, Sperk G: Differential
regulation of adult and embryonic glutamate decarboxylases in rat
dentate granule cells after kainate-induced limbic seizures. Neuroscience
2000, 100:287-295.
61. Conway EM, Pollefeyt S, Cornelissen J, DeBaere I, Steiner-Mosonyi M, Ong K,
Baens M, Collen D, Schuh AC: Three differentially expressed survivin
cDNA variants encode proteins with distinct antiapoptotic functions.
Blood 2000, 95:1435-1442.
62. Tiveron MC, Hirsch MR, Brunet JF: The expression pattern of the
transcription factor Phox2 delineates synaptic pathways of the
autonomic nervous system. J Neurosci 1996, 16:7649-7660.
63. Schauwecker PE, Steward O: Genetic determinants of susceptibility to
excitotoxic cell death: implications for gene targeting approaches. Proc
Natl Acad Sci USA 1997, 94:4103-4108.
64. Hogg S: A review of the validity and variability of the elevated plus-
maze as an animal model of anxiety. Pharmacology, biochemistry, and
behavior 1996, 54:21-30.
65. Miyakawa T, Yamada M, Duttaroy A, Wess J: Hyperactivity and intact
hippocampus-dependent learning in mice lacking the M1 muscarinic
acetylcholine receptor. J Neurosci 2001, 21:5239-5250.
66. Picciotto MR, Wickman K: Using knockout and transgenic mice to study
neurophysiology and behavior. Physiological reviews 1998, 78:1131-1163.
67. Paradee W, Melikian HE, Rasmussen DL, Kenneson A, Conn PJ, Warren ST:
Fragile × mouse: strain effects of knockout phenotype and evidence
suggesting deficient amygdala function. Neuroscience 1999, 94:185-192.
68. Paylor R, Tracy R, Wehner J, Rudy JW: DBA/2 and C57BL/6 mice differ in
contextual fear but not auditory fear conditioning. Behavioral
neuroscience 1994, 108:810-817.
Coremans et al. BMC Neuroscience 2010, 11:2
http://www.biomedcentral.com/1471-2202/11/2
Page 18 of 19
69. Aloe L, Properzi F, Probert L, Akassoglou K, Kassiotis G, Micera A, Fiore M:
Learning abilities, NGF and BDNF brain levels in two lines of TNF-alpha
transgenic mice, one characterized by neurological disorders, the other
phenotypically normal. Brain Res 1999, 840:125-137.
70. D’Hooge R, De Deyn PP: Applications of the Morris water maze in the
study of learning and memory. Brain research 2001, 36:60-90.
doi:10.1186/1471-2202-11-2
Cite this article as: Coremans et al.: Impaired neurogenesis, learning and
memory and low seizure threshold associated with loss of neural
precursor cell survivin. BMC Neuroscience 2010 11:2.
Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Coremans et al. BMC Neuroscience 2010, 11:2
http://www.biomedcentral.com/1471-2202/11/2
Page 19 of 19
